A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

July 31, 2003

Conditions
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile DiarrheaAntibiotic-associated ColitisAntibiotic-associated Diarrhea
Interventions
DRUG

GT160-246

Trial Locations (99)

10010

New York

10032

New York

11030

Manhasset

11432

Jamaica

13210

Syracuse

14215

Buffalo

15261

Pittsburgh

17033

Hershey

18105

Allentown

19013

Upland

19102

Philadelphia

19129

Philadelphia

19140

Philadelphia

19718

Newark

20815

Chevy Chase

21215

Baltimore

22042

Falls Church

23249

Richmond

23294

Richmond

28203

Charlotte

28801

Asheville

29425

Charleston

30106

Austell

31902

Columbus

32806

Orlando

33021

Hollywood

33511

Brandon

33744

Bay Pines

34102

Naples

36617

Mobile

37043

Clarksville

38104

Memphis

40202

Louisville

43215

Columbus

43608

Toledo

47203

Columbus

50309

Des Moines

50314

Des Moines

58122

Fargo

60064

North Chicago

60153

Maywood

60611

Chicago

63110

St Louis

65807

Springfield

67214

Wichita

70112

New Orleans

72205

Little Rock

73104

Oklahoma City

76508

Temple

85006

Phoenix

85724

Tucson

95816

Sacramento

98104

Seattle

40536-0084

Lexington

02111

Boston

02185

Braintree

02132

West Roxbury

08084

Stratford

T2N 1T9

Calgary

V5Z 3J5

Vancouver

V6Z 1Y6

Vancouver

R3A 1R9

Winnipeg

E1C 6Z8

Moncton

K1H 8L6

Ottawa

N9A 1C9

Windsor

G7H 5H6

Chicoutimi

H1T 2M4

Montreal

H2L 4M1

Montreal

H3T 1E2

Montreal

G1R 2J6 and G1L 3L5

Québec

G9A 1Y1

Trois-Rivières

00918

Hato Rey

CF4 4XW

Heathpark

CF64 2XX

Penlan Rd

BD20 6TD

Steeton

BL9 7TD

Bury

SW10 9NH

Chelsea

SW7 2AZ

South Kensington

NE7 7DN

High Heaton

NN1 5BD

Cliftonville

PR7 1PP

Fulwood

FK8 2AU

Livilands

SA6 6NL

Morriston

B18 7QH

Birmingham

B95SS

Birmingham

CB2 2QQ

Cambridge

EH4 2XU

Edinburgh

G21 3UR

Glasgow

HU3 2JZ

Hull

LS1 3EX

Leeds

LE1 5WW

Leicester

N19 5LW

London

SW17 0QT

London

W1N 8AA

London

NP20 2UB

Newport

NG7 2UH

Nottingham

SY3 8XQ

Shrewsbury

TA1 5DA

Taunton

WV10 0QP

Wolverhampton

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00034294 - A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea | Biotech Hunter | Biotech Hunter